ChrysCapital Increases Stake in RPG Life Sciences to 7.04%
RPG Life Sciences Ltd 路 Acquisition/ Disposal of Shares 路 28 Sept 2026, 7:43 pm
ChrysCapital Increases Stake in RPG Life Sciences to 7.04% Clarus Capital I acquired 37,463 equity shares (0.23% stake) of RPG Life Sciences Limited via open market purchases on 25th Sep'26. Consequently, the aggregate shareholding of the acquirers鈥擟larus Trust schemes managed by ChrysCapital Associates LLP鈥攁long with PAC ClearEdge LLC, rose from 11,26,278 shares (6.81%) to 11,63,741 shares (7.04%) of the total voting capital. Total equity share capital remains unchanged at Rs 13.23 crore comprising 1,65,39,015 equity shares of face value Rs 8 each.
Original exchange filing (PDF)
More announcements from RPG Life Sciences Ltd
- Earning call Transcript 路 05 Nov 2026
- Audio Recording of Q2FY27 Results Earnings Call held on October 30, 2026 路 31 Oct 2026
- Investor Presentation 路 30 Oct 2026
- Amendment to Policy on Related Party Transactions 路 30 Oct 2026
- Press Release 路 30 Oct 2026
- Outcome of Board Meeting held on October 29, 2026. 路 30 Oct 2026
- Financial Result for the quarter ended September 30, 2026 路 30 Oct 2026
- Outcome of Board Meeting 路 30 Oct 2026
